Interactions of Emerging Bunyaviruses with Host Cells
新兴布尼亚病毒与宿主细胞的相互作用
基本信息
- 批准号:7670061
- 负责人:
- 金额:$ 33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-03 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:Abortion RatesAcuteAfricaAndes VirusAntibodiesAntiviral AgentsBiological AssayBunyaviridaeCase Fatality RatesCategoriesCell CommunicationCellsCenters for Disease Control and Prevention (U.S.)Cherry - dietaryCodon NucleotidesCollaborationsComputer Retrieval of Information on Scientific Projects DatabaseCulicidaeDatabasesDevelopmentDisease OutbreaksDomestic AnimalsEconomicsEmerging Communicable DiseasesFamilyFeverFundingGenesGeneticGenomeGenus PhlebovirusGoalsGrantHantavirusHantavirus Pulmonary SyndromeHemorrhagic Fever with Renal SyndromeHepaticHumanInfectionInsectaKenyaLibrariesMammalian CellNairovirusOrthobunyavirusPathway interactionsPennsylvaniaPuumala virusRNA InterferenceReagentRequest for ApplicationsResearch PersonnelRetinalRift Valley fever virusRodentScreening procedureSeriesSin Nombre virusSymptomsTestingTherapeuticTherapeutic InterventionUnited States Department of AgricultureUniversitiesVaccinesViralVirusVirus ReplicationWorkbasebiodefensecell typecellular targetinghigh throughput technologymemberpathogensmall moleculesmall molecule librariestool
项目摘要
The family Bunyaviridae consists of over 300 viruses with members of four Bunyaviridae genera (Hantavirus,
Orthobunyavirus, Phlebovirus and Nairovirus) infecting humans. A number of the Hantaviruses and Rift
Valley Fever virus (RVFV, a Phlebovirus) are Category A agents with RVFV being of particular concern.
RVFV, which is spread by infected mosquitoes, was first described in Kenya in 1931 and has since been
documented throughout much of Africa and the Arabian peninsula. RVFV causes acute fevers and,
sometimes, retinal or hepatic complications with hemorrhagic symptoms. A recent outbreak in Kenya had a
case-fatality rate of greater than 20% for those with severe illness. In addition, RVFV causes catastrophic
abortion rates in domesticated animals, and thus can causes significant economic losses. As a result, it is
categorized as an overlap select agent by both the CDC and the US Department of Agriculture. Also of
concern are a number of Hantaviruses that cause hantavirus pulmonary syndrome (HPS) and/or
hemorrhagic fever with renal syndrome (HFRS) in humans. Included among these rodent-borne viruses are
Sin Nombre virus, Andes virus, and Puumala virus. RVFV and hantaviruses are under-studied pathogens
for which there are no approved vaccines or therapeutics. With support from the MARCE beginning in 2005,
we launched an effort to study RVFV and, more recently, several hantaviruses. Working with colleagues at
USAMRIID, the CDC and at Penn, we have developed a series of genetic tools and functional assays that
are being used in high throughput, whole genome RNAi and chemical library screens to identify host cell
molecules and pathways needed for the replication and dissemination of these viruses. Significant progress
with RVFV has already been made. By studying several bunyaviruses, we hope to identify cellular pathways
that are common to this virus family, as well as to identify cellular molecules that are uniquely important to
specific viral agents. The overall goal of our project is to identify host cell targets for therapeutic intervention.
Specifically, we propose to:
1. Complete our whole genome RNAi and chemical library screens with RVFV, validate hits and
determine mechanism of action.
2. Develop the genetic tools, assays and reagents needed to perform whole genome RNAi and
chemical library screens for Sin Nombre virus.
3. Determine breadth of action by testing against Andes and Puumala.
布尼亚病毒科由超过300种病毒组成,其成员为布尼亚病毒科的四个属(汉坦病毒,
正布尼亚病毒、白蛉病毒和内罗病毒)感染人类。一些汉坦病毒和裂谷病毒
谷热病毒(RVFV,一种白蛉病毒)是A类病原体,其中RVFV特别令人关注。
RVFV由受感染的蚊子传播,于1931年首次在肯尼亚被描述,此后一直被
在非洲和阿拉伯半岛的大部分地区都有记载。RVFV引起急性发热,
有时,视网膜或肝脏并发症伴有出血症状。最近在肯尼亚爆发的一场疫情
重症患者病死率超过20%。此外,RVFV还造成灾难性的
这可能会导致家畜流产率上升,从而造成重大经济损失。因此,
被CDC和美国农业部归类为重叠选择剂。评价很
令人担忧的是许多引起汉他病毒肺综合征(HPS)和/或
肾综合征出血热(HFRS)。这些啮齿动物传播的病毒包括
Sin Nombre病毒、安第斯山脉病毒和普马拉病毒。RVFV和汉坦病毒是研究不足的病原体
目前还没有批准的疫苗或治疗方法。在2005年开始的农业和农村经济改革委员会的支持下,
我们开始了对RVFV的研究,最近又开始了对几种汉坦病毒的研究。与同事一起工作,
USAMRIID,CDC和宾夕法尼亚大学,我们已经开发了一系列遗传工具和功能测定,
正在用于高通量、全基因组RNAi和化学文库筛选以鉴定宿主细胞
这些病毒复制和传播所需的分子和途径。重大进展
RVFV已经有了。通过研究几种布尼亚病毒,我们希望能够确定细胞途径
这是共同的病毒家族,以及确定细胞分子,是独特的重要,
特定的病毒因子。我们项目的总体目标是确定治疗干预的宿主细胞靶点。
具体而言,我们建议:
1.用RVFV完成我们的全基因组RNAi和化学文库筛选,验证命中,
确定作用机制。
2.开发进行全基因组RNAi所需的遗传工具、测定和试剂,
化学库筛选辛农布尔病毒
3.通过对安第斯山脉和普马拉的测试来确定行动的广度。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert W. Doms其他文献
HIV entry: are all receptors created equal?
HIV 进入:所有受体都是平等产生的吗?
- DOI:
10.1038/ni819 - 发表时间:
2002-07-01 - 期刊:
- 影响因子:27.600
- 作者:
Mark A. Goldsmith;Robert W. Doms - 通讯作者:
Robert W. Doms
Regulation of protein export from the endoplasmic reticulum.
内质网蛋白质输出的调节。
- DOI:
- 发表时间:
1988 - 期刊:
- 影响因子:0
- 作者:
J. Rose;Robert W. Doms - 通讯作者:
Robert W. Doms
Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells
阿尔茨海默病 Aβ(1–42) 在 NT2N 细胞的内质网/中间区室中生成。
- DOI:
10.1038/nm0997-1021 - 发表时间:
1997-09-01 - 期刊:
- 影响因子:50.000
- 作者:
David G. Cook;Mark S. Forman;Jane C. Sung;Susan Leight;Dennis L. Kolson;Takeshi Iwatsubo;Virgina M.-Y. Lee;Robert W. Doms - 通讯作者:
Robert W. Doms
Chemokines and coreceptors in HIV/SIV-host interactions.
HIV/SIV-宿主相互作用中的趋化因子和辅助受体。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:0
- 作者:
T. L. Hoffman;Robert W. Doms - 通讯作者:
Robert W. Doms
Coreceptor/Chemokine Receptor Expression on Human Hematopoietic Cells: Biological Implications for Human Immunodeficiency Virus–Type 1 Infection: Presented in part at the American Society of Hematology Meeting, San Diego, CA, 1997 and published in abstract form in Blood<em>90:2144, 1997 (abstr, suppl 1).</em>
- DOI:
10.1182/blood.v93.4.1145 - 发表时间:
1999-02-15 - 期刊:
- 影响因子:
- 作者:
Benhur Lee;Janina Ratajczak;Robert W. Doms;Alan M. Gewirtz;Mariusz Z. Ratajczak - 通讯作者:
Mariusz Z. Ratajczak
Robert W. Doms的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert W. Doms', 18)}}的其他基金
Interactions of Emerging Bunyaviruses with Host Cells
新兴布尼亚病毒与宿主细胞的相互作用
- 批准号:
8233375 - 财政年份:2011
- 资助金额:
$ 33万 - 项目类别:
Finger Nucleases to Specifically Disrupt Coreceptor Expression
特异性破坏辅助受体表达的指状核酸酶
- 批准号:
7668215 - 财政年份:2009
- 资助金额:
$ 33万 - 项目类别:
Crimean congo hemorrhagic fever virus glycoproteins
克里米亚刚果出血热病毒糖蛋白
- 批准号:
6856987 - 财政年份:2005
- 资助金额:
$ 33万 - 项目类别:
Crimean congo hemorrhagic fever virus glycoproteins
克里米亚刚果出血热病毒糖蛋白
- 批准号:
7028300 - 财政年份:2005
- 资助金额:
$ 33万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 33万 - 项目类别:
Operating Grants